Are you Dr. Kurtoglu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bldg 10 Room 12n226
Bethesda, MD 20892Phone+1 301-496-4916
Summary
- Dr. Metin Kurtoglu, MD is an internist in Bethesda, Maryland. He is currently licensed to practice medicine in District of Columbia and Florida.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2010 - 2013
Istanbul University FomClass of 2002
Certifications & Licensure
DC State Medical License 2013 - 2014
FL State Medical License Active through 2014
Clinical Trials
- Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma Start of enrollment: 2018 Feb 26
Publications & Presentations
PubMed
- 126 citationsDifferential Toxic Mechanisms of 2-Deoxy-D-Glucose versus 2-Fluorodeoxy-D -Glucose in Hypoxic and Normoxic Tumor CellsMetin Kurtoglu, Johnathan C. Maher, Theodore J. Lampidis
Antioxidants & Redox Signaling. 2007-08-03 - 159 citations2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.Haibin Xi, Metin Kurtoglu, Huaping Liu, Medhi Wangpaichitr, Min You
Cancer Chemotherapy and Pharmacology. 2011-04-01 - 81 citationsHypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.Johnathan C. Maher, Medhi Wangpaichitr, Niramol Savaraj, Metin Kurtoglu, Theodore J. Lampidis
Molecular Cancer Therapeutics. 2007-02-01
Press Mentions
Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate CuresMay 9th, 2021
A More Targeted CAR-T Cell-Based Therapy for Myasthenia Gravis Moves into Clinical Trial with University of FloridaNovember 7th, 2019
Cartesian Initiates CAR-T Clinical Trial in Myasthenia GravisNovember 5th, 2019
